Search results

4 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
American Society of Clinical Oncology's annual report features UNC Lineberger research
Research findings by Ethan Basch, MD, MSc, and Ronald C. Chen, MD, MPH, were cited as being among the most impactful advances and policy developments in cancer in 2017.
Located in News
More frequent screening after prostate cancer treatment not linked to improved survival
At the 2018 American Society of Clinical Oncology Annual Meeting, UNC Lineberger's Ronald Chen, MD, MPH, and colleagues presented findings from a study that assessed whether monitoring prostate cancer patients following treatment with a PSA test every three months versus once a year would provide a long-term survival benefit.
Located in News
UNC Lineberger researchers to study prostate cancer treatment side effects, survival outcomes
The use of robot-assisted surgery and modern radiation techniques have been rapidly adopted as treatments for prostate cancer, but a UNC Lineberger Comprehensive Cancer Center researcher is asking what the newer technologies will mean in terms of side effects and outcomes for patients in the long-term.
Located in News
Prostate cancer care for older men estimated to cost Medicare $1.2B
Researchers led by UNC Lineberger's Ronald C. Chen, MD, MPH, and Justin Trogdon, PhD, examined the costs associated with screening for prostate cancer, including treatment, for three years after diagnosis. They estimated that for men diagnosed in each of 2004, 2005, 2006, and 2007, the total cost for treating and screening for each group would be $1.2 billion for three years after diagnosis.
Located in News